Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.

about

Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.

Item

http://www.wikidata.org/entity/Q40125324

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bone marrow infiltration by mu ...... disruption of erythropoiesis.

@en

type

Item

label

Bone marrow infiltration by mu ...... disruption of erythropoiesis.

@en

prefLabel

Bone marrow infiltration by mu ...... disruption of erythropoiesis.

@en

P1476

Bone marrow infiltration by mu ...... disruption of erythropoiesis.

@en

P2093

Anass Bouchnita

http://www.w3.org/2001/XMLSchema#string

Mark J Koury

http://www.w3.org/2001/XMLSchema#string

Nathalie Eymard

http://www.w3.org/2001/XMLSchema#string

Tamara K Moyo

http://www.w3.org/2001/XMLSchema#string

Vitaly Volpert

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages

Role of the macrophage in erythropoiesis.

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.

P304

371-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24291

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289970937

http://www.w3.org/2001/XMLSchema#string

P698

26749142

http://www.w3.org/2001/XMLSchema#string